FDA wants new tri­al of Ac­tini­um’s ra­dioac­tive io­dine drug, com­pa­ny to seek part­ner 

Ac­tini­um Phar­ma­ceu­ti­cals is no longer plan­ning to move for­ward with its io­dine-based drug in­de­pen­dent­ly af­ter the FDA said a new clin­i­cal tri­al would be need­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER